Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $28.7 Million - $33.6 Million
-1,135,400 Reduced 89.54%
132,600 $3.71 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $31.2 Million - $35.9 Million
1,206,500 Added 1961.79%
1,268,000 $35.2 Million
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $26,130 - $33,940
-1,000 Reduced 1.6%
61,500 $1.77 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $940,237 - $1.1 Million
-29,300 Reduced 31.92%
62,500 $2.07 Million
Q2 2023

Aug 15, 2023

BUY
$36.12 - $41.79 $158,928 - $183,876
4,400 Added 5.03%
91,800 $3.37 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $2.55 Million - $3.32 Million
64,700 Added 285.02%
87,400 $3.57 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $442,550 - $577,700
-10,600 Reduced 31.83%
22,700 $1.16 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $40.1 Million - $49 Million
-917,015 Reduced 96.5%
33,300 $1.46 Million
Q2 2022

Aug 12, 2022

BUY
$46.53 - $55.17 $158,899 - $188,405
3,415 Added 0.36%
950,315 $49.8 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $41.3 Million - $51.1 Million
901,885 Added 2003.52%
946,900 $49 Million
Q1 2021

May 13, 2021

SELL
$33.49 - $37.77 $1.86 Million - $2.1 Million
-55,600 Reduced 55.26%
45,015 $1.63 Million
Q4 2020

Feb 09, 2021

SELL
$33.47 - $42.56 $2.77 Million - $3.52 Million
-82,800 Reduced 45.14%
100,615 $28,000
Q3 2020

Nov 05, 2020

BUY
$31.75 - $37.25 $4.73 Million - $5.55 Million
149,000 Added 432.95%
183,415 $63,000
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $132,528 - $160,776
4,400 Added 14.66%
34,415 $44,000
Q1 2020

May 14, 2020

BUY
$27.03 - $38.62 $811,305 - $1.16 Million
30,015 New
30,015 $53,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $163B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.